The knockdown of KAT2B decreases its binding and reduces H4K5 acetylation at IL-10 promoter regions, leading to the transcriptional silencing of the anti-inflammatory cytokine IL-10 in inflamed IBD tissues. This evidence concerns the gene IL10 and inflammatory bowel disease.